Copyright
©The Author(s) 2020.
World J Clin Cases. Dec 6, 2020; 8(23): 5935-5943
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5935
Published online Dec 6, 2020. doi: 10.12998/wjcc.v8.i23.5935
TILs phenotypes | CD155 expression | P value | |
Negative (n = 78) | Positive (n = 48) | ||
CD4+ TILs, mean ± SD | 54 ± 46 | 87 ± 93 | 0.041 |
CD4+/PD-1+ TILs, mean ± SD | 20 ± 24 | 47 ± 57 | 0.002 |
CD4+/PD-1- TILs, mean ± SD | 34 ± 30 | 41 ± 45 | 0.658 |
CD8+ TILs, mean ± SD | 21 ± 20 | 37 ± 44 | 0.040 |
CD8+/PD-1+ TILs, mean ± SD | 4 ± 5 | 7 ± 13 | 0.069 |
CD8+/PD-1- TILs, mean ± SD | 17 ± 17 | 30 ± 35 | 0.040 |
- Citation: Wang RB, Li YC, Zhou Q, Lv SZ, Yuan KY, Wu JP, Zhao YJ, Song QK, Zhu B. Overexpression of CD155 is associated with PD-1 and PD-L1 expression on immune cells, rather than tumor cells in the breast cancer microenvironment. World J Clin Cases 2020; 8(23): 5935-5943
- URL: https://www.wjgnet.com/2307-8960/full/v8/i23/5935.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i23.5935